Pernix Therapeutics competitorsClear all

Pernix Therapeutics's top competitors include Moderna Therapeutics, Alnylam Pharmaceuticals and Sorrento Therapeutics.
Pernix Therapeutics
Pernix Therapeutics
Pernix Therapeutics develops and markets branded and generic pharmaceutical products for the pediatric market.
Moderna Therapeutics
Moderna Therapeutics
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Founding Date
Founding Date
1997
Founding Date
N/A
Founding Date
2002
Founding Date
2006
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Morristown, US HQ
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Cambridge, US
Norwood, US
Chicago, US
Huntington, US
Locations
Cambridge, US HQ
Zug, CH
Windsor And Maidenhead, GB
Locations
San Diego, US HQ
Employees
Employees
171
Employees
76012% increase
Employees
1,06542% increase
Employees
382136% increase
Valuation ($)
Valuation ($)
3 m
Valuation ($)
5.2 b
Valuation ($)
7.5 b
Valuation ($)
368.9 m
Twitter followers
Twitter followers
308
Twitter followers
3.7 k
Twitter followers
10.8 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
52
Number of tweets (last 30 days)
40
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.3
Average likes per tweet (last 30 days)
9.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
756468
Alexa Website Rank
329468
Alexa Website Rank
449862
Alexa Website Rank
485704

Financial

Revenue (est.)
Revenue (est.)
$146.1m (FY, 2017)
Revenue (est.)
$135.1m (FY, 2018)
Revenue (est.)
$74.9m (FY, 2018)
Revenue (est.)
$21.2m (FY, 2018)
Cost of goods
Cost of goods
$44.6m (FY, 2017)
Cost of goods
N/A
Cost of goods
$1.8m (FY, 2018)
Cost of goods
$7.1m (FY, 2018)
Gross profit
Gross profit
$101.4m (FY, 2017)
Gross profit
N/A
Gross profit
$73.1m (FY, 2018)
Gross profit
$14.1m (FY, 2018)
Net income
Net income
($77.1m) (FY, 2017)
Net income
($384.7m) (FY, 2018)
Net income
($761.5m) (FY, 2018)
Net income
($212.5m) (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.8b
Total funding raised
$ 710m
Total funding raised
$ 42.6m
For sources of this data, please see the company profile

View company profiles

Moderna Therapeutics
HQ
Cambridge, US
Employees
760↑ 12% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,065↑ 42% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Sorrento Therapeutics
HQ
San Diego, US
Employees
382

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company